New Hampshire Non-Local Sources NH

FDA says current dose of GSK-Vir COVID therapy likely not effective against BA.2 variant

Daily Mail on New Hampshire

Mar 25, 2022

March 25 (Reuters) - The U.S. health regulator said on Friday the current authorized dose of GlaxoSmithKline and Vir Biotechnology's antibody-based...

Read the full story at Daily Mail on New Hampshire

Topics

#Coronavirus

FDA says current dose of GSK-Vir COVID therapy likely not effective against BA.2 variant

Topics

More from New Hampshire Non-Local Sources

Newsom declares 'Trump is in retreat' after Noem ouster, demands Miller be 'next'

Alleged New Hampshire country club shooter said he was targeting wealthy 'elites': report

Buttigieg, Newsom, AOC top three in new 2028 poll in key presidential primary state

Newsom stop in key presidential primary state sparks more 2028 speculation

Trump backs former critic Sununu in high-stakes swing state Senate race

Episcopal bishop warns clergy to prepare for 'new era of martyrdom' after ICE shooting

Brown University, MIT shooting suspect likely died days before body found: autopsy

New Hampshire 6-year-old tests positive for cocaine, cannabis; mother faces multiple charges